Goldstein: Expect More Litigation After Myriad

June 13 (Bloomberg Law) -- Tom Goldstein, partner at Goldstein & Russell, PC and founder of SCOTUSblog, talks with Bloomberg Law's Lee Pacchia about the United States Supreme Court's decision in the Association for Molecular Pathology v. Myriad Genetics, Inc. case. At issue was whether patents may be granted on parts of the human body. He also explores whether Justice Scalia's concurrence raises doubts whether he believes in molecular biology, and where patent litigation will head in the wake of the decision. Bloomberg Law is a sponsor of SCOTUSblog.
Cuban Envoy Says Progress Made on Normalizing U.S. Ties
48:45 - Feb. 27 -- Cuban Director of U.S. Policy Josefina Vidal speaks about negotiations on normalizing diplomatic relations between the U.S. and Cuba. She speaks at a news conference in Washington.
  • Remembering Former AIG CEO Bob Benmosche
  • House of Cards Season 3 Now on Netflix
  • Is America Facing a Third War in Iraq?